TECHNOLOGY | Camstent

camstent technology

The Camstent bacteria-phobic coating technology offers unique clinical advantages:

Demonstrably superior resistance to biofilm development.
Inert coating material, with documented compliance with laboratory biocompatibility standards for avoiding toxicity, irritation, and sensitisation.
Durable coating that remains attached to the catheter surface, inside the lumen and across the surface, throughout normal use
Smooth, thin surface coating aiming to minimise discomfort for the patient
Indications for use, handling, and training are unchanged from use of uncoated catheters.
Non-pharmacologic and does not kill bacteria, avoiding the emergence of resistant organisms.
Camstent can successfully coat surfaces manufactured from: Silicone, Latex & Silicone Latex, Polyolefin based Elastomer (POBE), PVC, Polyurethane, TPE, Poly Ethylene, LDPE & LLDPE, Nylon

Our USPs

Unmet need: many patient groups and devices will benefit from Camstent’s single platform innovation
Unique proven technology: ‘non-stick’ coating material, with growing body of clinical evidence for preventing build up of infectious organisms, lowering costs and improving patient outcomes. Low friction surface enhances patient comfort and minimises adhesions
Low product risk: approved for sale in EU and manufacturing approval complete. Strong clinical and business partnership interest as commercialisation gets underway
Strong IP position: strong patent protection, exclusive technology license, proprietary process knowhow
New product opportunities: entering new fields of medicine de-risks current offering. Targeting new products that are high value, high margin and high performance
Clear development path: leveraging materials and processes will enable company to meet opportunities for customer sales, new product lines, and global partnerships
entering new fields of medicine de-risks current offering.

our Standards

Camstent works to the highest quality standards. For more information, click here

the Problem

Urinary Tract Infections (UTI's) resulting from catheter use are the primary cause of hospital acquired infections. This impacts patient wellness resulting in longer hospitalisation, use of antibiotics and impacts healthcare costs.

the challenge

Catheters with effective antibacterial coatings can reduce or slow down the formation of the bacterial biofilm which leads to UTI's. Coated catheters on the market, which mainly rely on silver hydrogel or antibiotics, have proven to be largely ineffective at preventing the growth of bacterial biofilm and, therefore, reducing UTI's. Multiple clinical trials report little to no efficacy for existing products.

the solution

Camstent has developed a novel, IP-protected polymer coating for catheters that inhibits the formation of bacterial biofilms. The product can be applied to silicone/silastic and many other plastic surfaces. The polymer coating resists the attachment of organisms that form toxic colonies, and reduces the presence of bacterial toxins, thus preventing patients from developing infections.